|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/52 | |
| C12P 19/62 | |||
| C12N 9/00 | |||
| C12N 15/63 |
| (11) | Patento numeris | 3385386 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16880824.4 |
| Europos patento paraiškos padavimo data | 2016-11-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/107039 |
| Data | 2016-11-24 |
| (87) | Numeris | WO 2017/114034 |
| Data | 2017-07-06 |
| (30) | Numeris | Data | Šalis |
| 201511028754 | 2015-12-31 | CN |
| (72) |
WANG, Yiguang, CN
JANG, Yang, CN
ZHAO, Xiaofeng, CN
HE, Weiqing, CN
DAI, Jianlu, CN
|
| (73) |
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.,
No.18-12 Yaoyang Street Shenbei New District, Shenyang, Liaoning 110013,
CN
|
| (54) | CARRIMYCIN BIOSYNTHETIC GENE CLUSTER |
| CARRIMYCIN BIOSYNTHETIC GENE CLUSTER |